In a regulatory filing, Bristol Myers (BMY) disclosed that its Chief Medical Officer Samit Hirawat bought 4,250 shares of common stock on April 25th in a total transaction size of $202K.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers price target lowered to $47 from $56 at HSBC
- Bristol Myers price target lowered to $52 from $54 at UBS
- Bristol Myers price target raised to $56 from $54 at BofA
- Bristol Myers price target lowered to $53 from $62 at Wells Fargo
- Bristol-Myers Squibb: Hold Rating Amidst Strong Q1 Performance and Long-Term Growth Challenges